A microRNA that regulates inflammation shows promise as a treatment for inflammatory diseases such as asthma and cancer, according to research published in Cell Reports.
The microRNA, known as miR-223, is highly expressed in blood cells that cause inflammation (neutrophils). When they’re working correctly, those blood cells help protect the human body against infections, but sometimes they damage host tissue instead of microbes, causing chronic inflammation and disease.
To uncover the link between miR-223 and inflammation, a Purdue University research team created a zebrafish totally deficient of miR-223. Then they cut off a small chunk of its fin.
“The inflammation was really robust,” said Qing Deng, a professor of biological sciences at Purdue and corresponding author of the paper. “Neutrophils accumulated at the wound and they just kept coming. This is consistent with the literature, but we wanted to understand why.”
Extensive gene expression analysis led them to pathway NF-kB, a protein complex found in nearly all animal cell types that regulates inflammation and cell proliferation. Heightened activation of this pathway is the cause of increased inflammation, although it’s limited to the deeper, or basal, layer of the epithelium. This means any therapeutics would need to reach the basal layer to work.
The same pathway plays an important role in human bronchial epithelial cells, which are critical in the development of asthma, according to the study. MiR-223 suppresses the pathway, which means supplementing it to epithelial cells could help control inflammatory disease.
“We don’t have human trials yet, but we think it’s promising,” Deng said. “Instead of using steroids to drive away the immune cells, maybe this microRNA could be given.”
Learn more: MicroRNA could help treat cancer and asthma
The Latest on: MicroRNA
- CMTCN: a web tool for investigating cancer-specific microRNA and transcription factor co-regulatory networks on November 12, 2018 at 1:51 am
This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for ... […]
- Tracking down microRNA candidates linked to disease on November 7, 2018 at 12:48 am
What started as Ninad Oak's side project turned out into something much larger, his doctorate thesis. "The project started as my qualifying exam that I proposed at the end of my first year of graduate ... […]
- Tracking down microRNA candidates that can contribute to disease on November 6, 2018 at 10:14 am
A novel computational tool called ADmiRE extensively annotates human microRNA variants to determine which ones are likely to contribute to or cause diseases. "The project started as my qualifying exam ... […]
- With its back against the wall, Regulus hands over its lead microRNA drug to Sanofi for a small down payment on November 6, 2018 at 4:55 am
which originally came with $750 million in milestones during sunnier times for the microRNA company. The company stock was buoyed by the sight of cash, with shares surging 21% on the news. […]
- DiamiR Announces Two Publications on microRNA Biomarkers and Mechanisms of Aging on November 5, 2018 at 6:55 pm
MONMOUTH JUNCTION, N.J., Nov. 5, 2018 /PRNewswire/ -- DiamiR, a developer of innovative, minimally invasive diagnostic tests for neurodegenerative and other diseases, announced today two ... […]
- Safe and effective superoxide dismutase 1 silencing using artificial microRNA in macaques on October 31, 2018 at 12:07 pm
1 Horae Gene Therapy Center, University of Massachusetts Medical School, 368 Plantation Street, Worcester, MA 01605, USA. 2 Shire, 125 Binney Street, Cambridge, MA 02142, USA. 3 Department of Neurolog... […]
- Liquid-biopsy microRNA biomarkers to predict risk for diabetic kidney disease on October 29, 2018 at 5:32 am
A recent study from the Madras Diabetes Research Foundation, Chennai, India and University of Lyon, France, brings new hope for using 'liquid-biopsy' exosomal microRNA biomarkers (miRNAs) from ... […]
- Facts about Crohn's disease on October 16, 2018 at 9:11 pm
In a study published in the journal JCI Insight, researchers at the University of North Carolina reported that they have pinpointed a single molecule – microRNA-31 (miR-31) – the levels of which predi... […]
- Systemic control of legume susceptibility to rhizobial infection by a mobile microRNA on October 15, 2018 at 12:34 am
Nitrogen-fixing root nodules on legumes result from two developmental processes, bacterial infection and nodule organogenesis. To balance symbiosis and plant growth, legume hosts restrict nodule numbe... […]
- Systemic control of legume susceptibility to rhizobial infection by a mobile microRNA on August 30, 2018 at 3:33 pm
1 Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark. 2 Zentrum für Molekularbiologie der Pflanzen, Tübingen University, Tübingen, Germany. ↵#Corresponding author. Email: ... […]
via Google News and Bing News